Nifty99000 100%

Sensex99000 100%

Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
Article rating: No rating
RSS

News

India’s medical tourism industry to grow exponentially: Official

Author: IANS/Saturday, August 12, 2017/Categories: Healthcare

India’s medical tourism industry to grow exponentially: Official

New Delhi - India has gained popularity as a high quality medical care provider at affordable cost which can propel the country's medical tourism industry to grow exponentially, Rita Teaotia, Secretary, Ministry of Commerce, said.

Speaking at an event here to announce the launch dates for Advantage Healthcare India 2017, Teaotia said that apart from providing quality medical and medicinal care to foreign nationals, ancient science like treatment based on Ayurveda should also be promoted and showcased to international medical tourists.

"I am happy to see that many Ayush companies and institutions are also participating in Advantage Healthcare India 2017 this year. I wish that even the finest hospitals also have Ayush facilities. The finest hospitals of India should also provide Ayurvedic treatment" Teaotia said. 

The third international summit on medical value travel (medical tourism) is being jointly organised by Ficci, Ministry of Commerce and Industry and Service Export Promotion Council (SEPC) at Bengaluru from October 12-14, 2017.

Over 70 countries and 600 hosted buyers from Africa, Middle East, Europe, US, UK, and Asia (including Saarc) are expected to participate in the mega-event.

According to A.Didar Singh, Secretary General, Ficci the medical value travel can become a "$9 billion opportunity for India by 2020".

"To fully exploit this potential, the country needs to diversify its sources of medical tourism and create a strong value proposition for foreign patients by focusing on perimeters like cost effectiveness, alternate medicine, clinical outcomes, tourism friendliness, accreditation, and patient centricity," Singh said.

A recent Ficci-IMS report has pointed out that more than 500,000 foreign patients seek treatment in India each year, making it a key medical tourism destination in Asia.

Print Rate this article:
No rating

Number of views (311)/Comments (0)

S Vijaykrishnan
S Vijaykrishnan

IANS

Other posts by IANS
Contact author

Leave a comment

Name:
Email:
Comment:
Add comment

Name:
Email:
Subject:
Message:
x

Videos

Ask the Finapolis.

I'm not a robot
 
Dharmendra Satpathy
Col. Sanjeev Govila (retd)
Hum Fauji Investments
 
The Finapolis' expert answers your queries on investments, taxation and personal finance. Want advice? Submit your Question above
Want to Invest
 
 

Categories

Disclaimer

The technical studies / analysis discussed here can be at odds with our fundamental views / analysis. The information and views presented in this report are prepared by Karvy Consultants Limited. The information contained herein is based on our analysis and upon sources that we consider reliable. We, however, do not vouch for the accuracy or the completeness thereof. This material is for personal information and we are not responsible for any loss incurred based upon it. The investments discussed or recommended in this report may not be suitable for all investors. Investors must make their own investment decisions based on their specific investment objectives and financial position and using such independent advice, as they believe necessary. While acting upon any information or analysis mentioned in this report, investors may please note that neither Karvy nor Karvy Consultants nor any person connected with any associate companies of Karvy accepts any liability arising from the use of this information and views mentioned in this document. The author, directors and other employees of Karvy and its affiliates may hold long or short positions in the above mentioned companies from time to time. Every employee of Karvy and its associate companies is required to disclose his/her individual stock holdings and details of trades, if any, that they undertake. The team rendering corporate analysis and investment recommendations are restricted in purchasing/selling of shares or other securities till such a time this recommendation has either been displayed or has been forwarded to clients of Karvy. All employees are further restricted to place orders only through Karvy Consultants Ltd. This report is intended for a restricted audience and we are not soliciting any action based on it. Neither the information nor any opinion expressed herein constitutes an offer or an invitation to make an offer, to buy or sell any securities, or any options, futures or other derivatives related to such securities.

Subscribe For Free

Get the e-paper free